JUNE 2015 ARTICLE LIST >>
PharmaTutor (June- 2015)
Print-ISSN: 2394 - 6679
e-ISSN: 2347 - 7881
(Volume 3, Issue 6)
Received On: 12/03/2015; Accepted On: 16/03/2015; Published On: 01/06/2015
AUTHORS: Mali Audumbar*, Jadhav Santosh, Hake Gorakhnath, Tamboli Ashpak
Department of Pharmaceutics, Sahyadri College of Pharmacy, Methwade,
Sangola-413307, Solapur, Maharashtra, India.
maliaudu442@gmail.com
ABSTRACT: Simple, fast and reliable spectrophotometric methods were developed for determination of Fluoxetine Hydrochloride in bulk and pharmaceutical dosage forms. The solutions of standard and the sample were prepared in Distilled Water. The quantitative determination of the drug was carried out using the zero order derivative values measured at 226 nm and the area under the curve method values measured at 220-231 nm (n=2). Calibration graphs constructed at their wavelengths of determination were linear in the concentration range of Fluoxetine Hydrochloride using 5-25μg/ml (r²=0.999 and r²=0.997) for zero order and area under the curve spectrophotometric method. All the proposed methods have been extensively validated as per ICH guidelines. There was no significant difference between the performance of the proposed methods regarding the mean values and standard deviations. Developed spectrophotometric methods in this study are simple, accurate, precise and sensitive to assay of Fluoxetine Hydrochloride in tablets.
How to cite this article: A Mali, S Jadhav, G Hake, A Tamboli; Zero Order and Area under Curve Spectrophotometric Methods for Determination of Fluoxetine Hydrochloride in Pharmaceutical Formulation; PharmaTutor; 2015; 3(6); 49-54
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Rubesh kumar S, P Gayathri , Duganath N , Kiran CH , Sridhar C , Jayaveera K N; Simultaneous Estimation of Fluoxetine HCl and Olanzapine in Bulk Drug and Pharmaceutical Formulation by Using UV-Visible Spectroscopy Method; IJPSDR; 2011; 3(1); 52-55.
2. A. Mahmoud, Tantawy, Nagiba Y,Hassan, Nariman A.,Elargehy, Mohamed Abdel Kawy; Simultaneous determination of Fluoxetine Hydrochloride and Olnazipine in Capsules by Spectrophotometry, TLC-spectrodensitometry and RP-HPLC; Journal of advanced research; 2013; 4(2); 173-180.
3. I. A. Darwish; Devolopment and validation of spectrophotometric methods for the determination of Fluoxetine, Sertraline and Poroxetine in pharmaceutical dosage forms; Journal of AOAC International; 2005; 3(8); 88-97.
4. M. T Naik, M. D Rokade, P. M Dhadke; Extractive spectrophotometric estimation of Fluoxetine hydrochloride in Pharmaceutical formulation; Indian Journal of Phramaceutical Sciences; 1999; 61(3); 156-157.
5. Shubhnjali Shukla, Pankajkumar, N.S. Harinarayana Moorthy, Sushanth Kumar, Shrivasthava, Piyush Trivedi, Radheyshyam Srivastava; RP-HPLC method development and its validation for the simultaneous estimation of Alprzolam and Fluoxetine Hydrochloride in pharmaceutical dosage form; Eurasian Journal of Analytical chemistry; 2010; 5(3); 239-245.
6. A. E. Mohammed, M. M. Mokhtar, A. E. Fawzy; Liquid chromatographic determination of Fluoxetine Hydrochloride; Journal of pharmaceutical and Biomedical Analysis; 2002; 30(4); 851-856.
7. B. V. Reddy, KVNS Reddy, J. Sreeramulu, G. V. Kanumula; Simultaneous determination of Olanzipine and Fluoxetine by HPLC; Journal of Chromatography; 2007; 66(4); 111-114.
8. A. L. Peyton , R. Carpenter , K. Rutkowski; The stereospecific determination of Fluoxetine and Norfluoxetine enantiomers in human plasma by HPLC with fluorescence detection; Indian Journal of Pharmaceutical Sciences; 1991; 8(15); 28-32.
9. C. R. Shah, N. J. Shah, N.Suhagia, N. M. Patel; Simultaneous assay of Olnazipine and Fluoxetine tablets by column high-performance chromatography and HPTLC; Journal of AOAC International; 2007; 90(1); 573-578.
10. Sejal Patel, N. J. Patel; Simultaneous RP-HPLC and HPTLC estimation of Fluoxetine Hydrochloride and Olanzipine in tablet dosage forms; Indian Journal of Pharmaceutical Sciences; 2009; 71(4); 477-480.
11. International Conference on Harmonization (ICH) of Technical Requirements for the registration of Pharmaceuticals for Human use, Validation of Analytical Procedures Methodology; ICH-Q2(R1), Geneva, 1996; 1-8.
.png)
